BRISTOL-MYERS SQUIBB COMPANY Cost of Goods Sold (Deprecated 2018-01-31)
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Cost of Goods Sold (Deprecated 2018-01-31) of $1.65 billion for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-25.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-10-25
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $1.65B, a 4.37% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $1.63B, a 3.57% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $1.58B, a 25.22% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $1.65B, a 19.52% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $6.07B, a 22.64% increase from fiscal 2016.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $4.95B, a 26.53% increase from fiscal 2015.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $3.91B, a 0.58% decline from fiscal 2014.
- BRISTOL-MYERS SQUIBB COMPANY cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.93B, a 14.87% decline from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|---|
| 2018-09-30 | $1.65B 10-Q · filed 2018-10-25 | $3.27B derived: sum of 2 quarters · filed 2018-10-25 | $4.86B 10-Q · filed 2018-10-25 | $6.51B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2018-06-30 | $1.63B 10-Q · filed 2018-07-26 | $3.21B 10-Q · filed 2018-07-26 | $4.86B derived: sum of 3 quarters · filed 2018-07-26 | $6.44B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2018-03-31 | $1.58B 10-Q · filed 2018-04-26 | $3.24B derived: sum of 2 quarters · filed 2018-04-26 | $4.82B derived: sum of 3 quarters · filed 2018-10-25 | $6.38B derived: sum of 4 quarters · filed 2018-10-25 | |||
| 2017-12-31 | $1.65B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $3.23B derived: sum of 2 quarters · filed 2018-10-25 | $4.80B derived: sum of 3 quarters · filed 2018-10-25 | $6.07B 10-K · filed 2018-02-13 | |||
| 2017-09-30 | $1.58B 10-Q · filed 2018-10-25 | $1.57B 10-Q · filed 2017-10-26 | $3.15B derived: sum of 2 quarters · filed 2018-10-25 | $4.41B 10-Q · filed 2018-10-25 | $4.39B 10-Q · filed 2017-10-26 | $5.80B derived: sum of 4 quarters · filed 2018-10-25 | |
| 2017-06-30 | $1.57B 10-Q · filed 2018-07-26 | $1.56B 10-Q · filed 2017-07-27 | $2.83B 10-Q · filed 2018-07-26 | $2.82B 10-Q · filed 2017-07-27 | $4.22B derived: sum of 3 quarters · filed 2018-07-26 | $5.52B derived: sum of 4 quarters · filed 2018-07-26 | |
| 2017-03-31 | $1.26B 10-Q · filed 2018-04-26 | $1.26B 10-Q · filed 2017-04-27 | $2.65B derived: sum of 2 quarters · filed 2018-04-26 | $3.95B derived: sum of 3 quarters · filed 2018-04-26 | $5.16B derived: sum of 4 quarters · filed 2018-04-26 | ||
| 2016-12-31 | $1.38B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $2.69B derived: sum of 2 quarters · filed 2018-02-13 | $3.89B derived: sum of 3 quarters · filed 2018-02-13 | $4.95B 10-K · filed 2018-02-13 | |||
| 2016-09-30 | $1.30B 10-Q · filed 2017-10-26 | $2.51B derived: sum of 2 quarters · filed 2017-10-26 | $3.56B 10-Q · filed 2017-10-26 | $4.51B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $1.21B 10-Q · filed 2017-07-27 | $2.26B 10-Q · filed 2017-07-27 | $3.21B derived: sum of 3 quarters · filed 2018-02-13 | $4.31B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $1.05B 10-Q · filed 2017-04-27 | $2.00B derived: sum of 2 quarters · filed 2018-02-13 | $3.10B derived: sum of 3 quarters · filed 2018-02-13 | $4.11B derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | $952.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $2.05B derived: sum of 2 quarters · filed 2018-02-13 | $3.06B derived: sum of 3 quarters · filed 2018-02-13 | $3.91B 10-K · filed 2018-02-13 | |||
| 2015-09-30 | $1.10B 10-Q · filed 2016-10-27 | $2.11B derived: sum of 2 quarters · filed 2016-10-27 | $2.96B 10-Q · filed 2016-10-27 | $3.92B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $1.01B 10-Q · filed 2016-07-28 | $1.86B 10-Q · filed 2016-07-28 | $2.83B derived: sum of 3 quarters · filed 2017-02-21 | $3.83B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $847.00M 10-Q · filed 2016-04-28 | $1.81B derived: sum of 2 quarters · filed 2017-02-21 | $2.82B derived: sum of 3 quarters · filed 2017-02-21 | $3.81B derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | $966.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $1.97B derived: sum of 2 quarters · filed 2017-02-21 | $2.96B derived: sum of 3 quarters · filed 2017-02-21 | $3.93B 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $1.01B 10-Q · filed 2015-10-27 | $2.00B derived: sum of 2 quarters · filed 2015-10-27 | $2.97B 10-Q · filed 2015-10-27 | $4.24B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-30 | $991.00M 10-Q · filed 2015-07-23 | $1.96B 10-Q · filed 2015-07-23 | $3.23B derived: sum of 3 quarters · filed 2016-02-12 | $4.41B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-31 | $968.00M 10-Q · filed 2015-04-28 | $2.24B derived: sum of 2 quarters · filed 2016-02-12 | $3.42B derived: sum of 3 quarters · filed 2016-02-12 | $4.52B derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-31 | $1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $2.45B derived: sum of 2 quarters · filed 2016-02-12 | $3.56B derived: sum of 3 quarters · filed 2016-02-12 | $4.62B 10-K · filed 2016-02-12 | |||
| 2013-09-30 | $1.18B 10-Q · filed 2014-10-24 | $2.28B derived: sum of 2 quarters · filed 2014-10-24 | $3.35B 10-Q · filed 2014-10-24 | $4.42B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $1.11B 10-Q · filed 2014-07-24 | $2.17B 10-Q · filed 2014-07-24 | $3.25B derived: sum of 3 quarters · filed 2015-02-13 | $4.23B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $1.06B 10-Q · filed 2014-04-29 | $2.14B derived: sum of 2 quarters · filed 2015-02-13 | $3.13B derived: sum of 3 quarters · filed 2015-02-13 | $4.37B derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $2.06B derived: sum of 2 quarters · filed 2015-02-13 | $3.31B derived: sum of 3 quarters · filed 2015-02-13 | $4.61B 10-K · filed 2015-02-13 | |||
| 2012-09-30 | $987.00M 10-Q · filed 2013-10-23 | $2.23B derived: sum of 2 quarters · filed 2013-10-23 | $3.54B 10-Q · filed 2013-10-23 | $4.90B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-06-30 | $1.25B 10-Q · filed 2013-07-25 | $2.55B 10-Q · filed 2013-07-25 | $3.92B derived: sum of 3 quarters · filed 2014-02-14 | $5.32B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-03-31 | $1.30B 10-Q · filed 2013-04-25 | $2.67B derived: sum of 2 quarters · filed 2014-02-14 | $4.08B derived: sum of 3 quarters · filed 2014-02-14 | $5.56B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2011-12-31 | $1.37B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $2.77B derived: sum of 2 quarters · filed 2014-02-14 | $4.25B derived: sum of 3 quarters · filed 2014-02-14 | $5.60B 10-K · filed 2014-02-14 | |||
| 2011-09-30 | $1.41B 10-Q · filed 2012-10-24 | $2.89B derived: sum of 2 quarters · filed 2012-10-24 | $4.23B 10-Q · filed 2012-10-24 | $5.64B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $1.48B 10-Q · filed 2012-07-25 | $2.82B 10-Q · filed 2012-07-25 | $4.24B derived: sum of 3 quarters · filed 2013-02-15 | $5.52B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $1.34B 10-Q · filed 2012-04-26 | $2.76B derived: sum of 2 quarters · filed 2013-02-15 | $4.04B derived: sum of 3 quarters · filed 2013-02-15 | $5.31B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $2.69B derived: sum of 2 quarters · filed 2013-02-15 | $3.97B derived: sum of 3 quarters · filed 2013-02-15 | $5.28B 10-K · filed 2013-02-15 | |||
| 2010-09-30 | $1.28B 10-Q · filed 2011-10-27 | $2.56B derived: sum of 2 quarters · filed 2011-10-27 | $3.86B 10-Q · filed 2011-10-27 | $5.30B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $1.28B 10-Q · filed 2011-07-28 | $2.58B 10-Q · filed 2011-07-28 | $4.02B derived: sum of 3 quarters · filed 2012-02-17 | $5.33B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $1.31B 10-Q · filed 2011-04-28 | $2.74B derived: sum of 2 quarters · filed 2012-02-17 | $4.06B derived: sum of 3 quarters · filed 2012-02-17 | $5.28B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $2.75B derived: sum of 2 quarters · filed 2012-02-17 | $3.98B derived: sum of 3 quarters · filed 2012-02-17 | $5.14B 10-K · filed 2012-02-17 | |||
| 2009-09-30 | $1.32B 10-Q · filed 2010-10-26 | $1.56B 10-Q · filed 2009-10-22 | $2.54B derived: sum of 2 quarters · filed 2010-10-26 | $3.71B 10-Q · filed 2010-10-26 | $4.44B 10-Q · filed 2009-10-22 | $4.15B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $1.23B 10-Q · filed 2010-07-22 | $1.46B 10-Q · filed 2009-07-23 | $2.39B 10-Q · filed 2010-07-22 | $2.87B 10-Q · filed 2009-07-23 | $2.83B derived: sum of 3 quarters · filed 2011-02-18 | $4.47B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $1.17B 10-Q · filed 2010-04-29 | $1.61B derived: sum of 2 quarters · filed 2011-02-18 | $3.24B derived: sum of 3 quarters · filed 2011-02-18 | $4.91B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2008-12-31 | $442.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $2.08B derived: sum of 2 quarters · filed 2011-02-18 | $3.75B derived: sum of 3 quarters · filed 2011-02-18 | $5.32B 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $1.63B 10-Q · filed 2009-10-22 | $3.30B derived: sum of 2 quarters · filed 2009-10-22 | $4.87B 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $1.67B 10-Q · filed 2009-07-23 | $3.24B 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $4.92B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |